These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6304695)

  • 1. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
    Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
    Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
    Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
    J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
    Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
    Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.
    Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP
    Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
    Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
    J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin.
    Llorens-Cortes C; Schwartz JC
    Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
    van Amsterdam JG; van Buuren KJ; Soudijn W
    Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
    Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
    J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
    Aoki K; Kajiwara M; Oka T
    Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the inhibitory potencies of thiorphan and retrothiorphan enantiomers on thermolysin and neutral endopeptidase 24.11 and their interactions with the thermolysin active site by computer modelling.
    Benchetrit T; Fournié-Zaluski MC; Roques BP
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1034-40. PubMed ID: 3478046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.